Stakeholder perspectives on contributors to delayed and inaccurate diagnosis of cardiovascular disease: a UK-based qualitative study

Author:

Abdullayev KORCID,Gorvett O,Sochiera A,Laidlaw L,Chico TJAORCID,Manktelow MORCID,Buckley OORCID,Condell JORCID,Van Arkel RJORCID,Diaz-Zuccarini V,Matcham FaithORCID

Abstract

AbstractObjectiveThe aim of this study is to understand stakeholder experiences of cardiovascular disease (CVD) diagnosis to support the development of technological solutions that meet current needs. Specifically, we aimed to identify challenges faced by stakeholders in the process of diagnosis of CVD; to identify discrepancies between patient and clinician experiences of CVD diagnosis, and to make recommendations for the requirements of future health technology solutions intended to improve CVD diagnosis.DesignThe qualitative data was obtained using semi-structured focus groups and 1-1 interviews.ParticipantsUK-based individuals (N = 32) with lived experience of diagnosis of CVD (n = 23) and clinicians with experience in diagnosing CVD (n = 9).ResultsThematic analysis of focus groups and interview transcripts produced four key themes related to challenges contributing to delayed or inaccurate diagnosis of CVD: Symptom Interpretation, Patient Characteristics, Patient-Clinician Interactions, and Systemic Challenges. Sub-themes from each theme are discussed in depth.ConclusionsChallenges related to time and communication were greatest for both stakeholder groups, however there were differences in other areas, for example patient experiences highlighted difficulties with the psychological aspects of diagnosis and interpreting ambiguous symptoms, while clinicians emphasised the role of individual patient differences and the lack of rapport in contributing to delays or inaccurate diagnosis. Key takeaways from this qualitative study were summarised into a table of considerations to highlight key areas that require prioritisation for future research aiming to improve the efficiency and accuracy of CVD diagnosis using digital technologies.

Publisher

Cold Spring Harbor Laboratory

Reference53 articles.

1. Raleigh V , Jefferies D , Wellings D. Cardiovascular disease in England: supporting leaders to take actions [Internet]. The King’s Fund. 2022 [cited 2023 Jun 23]. Available from: https://www.kingsfund.org.uk/publications/cardiovascular-disease-england

2. Roth GA , Mensah GA , Johnson CO , Addolorato G , Ammirati E , Baddour LM , et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. Vol. 76, Journal of the American College of Cardiology. 2020.

3. European Society of Cardiology: Cardiovascular Disease Statistics 2019

4. Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK;Pharmacoeconomics,2023

5. Fry M , McLachlan S , Purdy S , Sanders T , Kadam UT , Chew-Graham CA . The implications of living with heart failure; The impact on everyday life, family support, co-morbidities and access to healthcare: A secondary qualitative analysis. BMC Fam Pract. 2016;17(1).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3